BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

894 related articles for article (PubMed ID: 12112380)

  • 1. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
    Meng Q; Su T; O'Neill JP; Walker VE
    Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative mutagenic potencies of several nucleoside analogs, alone or in drug pairs, at the HPRT and TK loci of human TK6 lymphoblastoid cells.
    Carter MM; Torres SM; Cook DL; McCash CL; Yu M; Walker VE; Walker DM
    Environ Mol Mutagen; 2007; 48(3-4):239-47. PubMed ID: 17358029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of Tk and Hprt lymphocyte mutants and bone marrow micronuclei in mice treated neonatally with zidovudine and didanosine.
    Von Tungeln LS; Dobrovolsky VN; Bishop ME; Shaddock JG; Heflich RH; Beland FA
    Mutagenesis; 2004 Jul; 19(4):307-11. PubMed ID: 15215330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant frequency and mutational spectra in the Tk and Hprt genes of N-ethyl-N-nitrosourea-treated mouse lymphoma cellsdagger.
    Chen T; Harrington-Brock K; Moore MM
    Environ Mol Mutagen; 2002; 39(4):296-305. PubMed ID: 12112381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotoxicity of 3'-azido-3'-deoxythymidine in the human lymphoblastoid cell line, TK6: relationships between DNA incorporation, mutant frequency, and spectrum of deletion mutations in HPRT.
    Sussman HE; Olivero OA; Meng Q; Pietras SM; Poirier MC; O'Neill JP; Finette BA; Bauer MJ; Walker VE
    Mutat Res; 1999 Oct; 429(2):249-59. PubMed ID: 10526209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity of zidovudine, lamivudine, and abacavir following in vitro exposure of human lymphoblastoid cells or in utero exposure of CD-1 mice to single agents or drug combinations.
    Torres SM; Walker DM; Carter MM; Cook DL; McCash CL; Cordova EM; Olivero OA; Poirier MC; Walker VE
    Environ Mol Mutagen; 2007; 48(3-4):224-38. PubMed ID: 17358033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of in vivo mutations induced by N-ethyl-N-nitrosourea in the autosomal Tk and the X-linked Hprt genes of mouse lymphocytes.
    Dobrovolsky VN; Chen T; Heflich RH
    Environ Mol Mutagen; 1999; 34(1):30-8. PubMed ID: 10462721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells.
    Olivero OA; Tejera AM; Fernandez JJ; Taylor BJ; Das S; Divi RL; Poirier MC
    Mutagenesis; 2005 Mar; 20(2):139-46. PubMed ID: 15784690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3'-azido-3'-deoxythymidine induces deletions in L5178Y mouse lymphoma cells.
    Wang J; Chen T; Honma M; Chen L; Moore MM
    Environ Mol Mutagen; 2007; 48(3-4):248-57. PubMed ID: 17358034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectra of X-ray-induced and spontaneous intragenic HPRT mutations in closely related human cells differentially expressing the p53 tumor suppressor gene.
    Phillips EN; Gebow D; Liber HL
    Radiat Res; 1997 Feb; 147(2):138-47. PubMed ID: 9008205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice.
    Walker VE; Gorelick NJ; Andrews JL; Craft TR; deBoer JG; Glickman BW; Skopek TR
    Cancer Res; 1996 Oct; 56(20):4654-61. PubMed ID: 8840980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectra of spontaneous and X-ray-induced mutations at the hprt locus in related human lymphoblast cell lines that express wild-type or mutant p53.
    Phillips EN; Xia F; Kelsey KT; Liber HL
    Radiat Res; 1995 Sep; 143(3):255-62. PubMed ID: 7652162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Hprt mutations in cDNA and genomic DNA of T-cell mutants from control and 1,3-butadiene-exposed male B6C3F1 mice and F344 rats.
    Meng Q; Walker DM; Scott BR; Seilkop SK; Aden JK; Walker VE
    Environ Mol Mutagen; 2004; 43(2):75-92. PubMed ID: 14991748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of mutations in the Tk gene of Tk(+/-) mice treated as neonates with 3'-azido-3'-deoxythymidine (AZT).
    Mittelstaedt RA; Von Tungeln LS; Shaddock JG; Dobrovolsky VN; Beland FA; Heflich RH
    Mutat Res; 2004 Mar; 547(1-2):63-9. PubMed ID: 15013700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zidovudine-didanosine coexposure potentiates DNA incorporation of zidovudine and mutagenesis in human cells.
    Meng Q; Walker DM; Olivero OA; Shi X; Antiochos BB; Poirier MC; Walker VE
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12667-71. PubMed ID: 11058153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplacental drug transfer and frequency of Tk and Hprt lymphocyte mutants and peripheral blood micronuclei in mice treated transplacentally with zidovudine and lamivudine.
    Von Tungeln LS; Williams LD; Doerge DR; Shaddock JG; McGarrity LJ; Morris SM; Mittelstaedt RA; Heflich RH; Beland FA
    Environ Mol Mutagen; 2007; 48(3-4):258-69. PubMed ID: 16850453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors.
    Olivero OA
    Environ Mol Mutagen; 2007; 48(3-4):215-23. PubMed ID: 16395695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic damage detected in CD-1 mouse pups exposed perinatally to 3'-azido-3'-deoxythymidine or dideoxyinosine via maternal dosing, nursing, and direct gavage: II. Effects of the individual agents compared to combination treatment.
    Witt KL; Tice RR; Wolfe GW; Bishop JB
    Environ Mol Mutagen; 2004; 44(4):321-8. PubMed ID: 15476197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.